| Literature DB >> 27997880 |
Martin Berger1, Alexander Roller2, Nuno Maulide3.
Abstract
Dehydroabietic acid (DHAA) plays an important role in drug discovery. Its modification at chemically reactive positions has been exploited to a large extent over the last decades, generating a wide range of analogues. In contrast, introduction of substituents at chemically inert positions remains a sizeable challenge. Hereby we wish to report the synthesis of a first series of C-19-arylated DHAA-analogues by application of a simple CH activation protocol, as well as their antimicrobial activity against methicillin resistant Staphylococcus aureus (MRSA).Entities:
Keywords: Antimicrobial; CH-activation; Dehydroabietic acid; Directing group; MRSA
Mesh:
Substances:
Year: 2016 PMID: 27997880 DOI: 10.1016/j.ejmech.2016.12.012
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 7.088